Table 3

Frequency of immunohistochemical expression of the examined biomarkers in nasopharyngeal carcinoma (sorted from the most frequently expressed to the least frequently ones)
Biomarker No of Cases Positive (%) Negative (%)
Multi-Cytokeratin 103 102 (99) 1 (1)
COX-2 94 90 (95.7) 4 (4.3)
P-cadherin 97 92 (94.8) 5 (5.2)
EBER 101 94 (93.1) 7 (6.9)
Phospho-GSK-3βSer9 100 92 (92) 8 (8)
Fascin-1 96 88 (91.7) 8 (8.3)
E-cadherin 94 83 (88.3) 11 (11.7)
p63 94 83 (88.3) 11 (11.7)
EGFR 95 83 (87.4) 12 (12.6)
p53 95 82 (86.3) 13 (13.7)
Phospho-AKTSer473 96 79 (82.3) 17 (17.7)
Ki67 100 78 (78) 22 (22)
ERCC1 105 78 (74.3) 27 (25.7)
MAPT (Tau) 104 74 (71.2) 30 (28.8)
VEGF-C 100 64 (64) 36 (36)
Phospho-p44/42 MAPKThr202/Tyr204 95 60 (63.2) 35 (36.8)
PTEN 102 64 (62.7) 38 (37.3)
VEGFR-3 101 60 (59.4) 41 (40.6)
Cyclin D1 102 53 (52) 49 (48)
VEGFR-2 95 44 (46.3) 51 (53.7)
Phospho-mTORSer2448 101 38 (37.6) 63 (62.4)
VEGF-A 100 36 (36) 64 (64)
p16 105 5 (4.8) 100 (95.2)

Krikelis et al.

Krikelis et al. BMC Clinical Pathology 2013 13:1   doi:10.1186/1472-6890-13-1

Open Data